In order to improve hammerhead ribozyme efficiency and specificity, we
have analyzed, both in vitro and in vivo, the activity of a series of
ribozyme/substrate combinations that have the same target sequence bu
t differ in the length of the ribozyme/substrate duplex or in their st
ructure, i.e., the total length of the RNA. In vitro, we have found th
at optimal kcat/Km (at 37 degrees C) is obtained when the ribozyme/sub
strate duplex has a length of 12 bases, which according to the base co
mposition represents a calculated free energy of binding of -16 kcal/m
ol. We discuss the importance of this value for ribozyme specificity a
nd present strategies that may improve it. Increasing the length of th
e duplex from 14 to 17 bases (from -19 to -26 kcal/mol) produces a red
uced ribozyme activity which is probably due to a slower rate of produ
ct dissociation. In addition, inclusion of either the substrate or the
ribozyme in a long transcript produces a reduction (10 fold) of the k
cat/Km, probably because of a different accessibility of the target se
quence. In vivo, the activity of the trans-acting ribozyme was extreme
ly low and detected in only one case: with a ribozyme/substrate duplex
length of 13 bases and with both ribozyme and substrate embedded in s
hort RNAs expressed at a very high level. The similarity of the result
s obtained in vitro and in vivo indicates that it is possible to use a
n in vitro system to optimize ribozymes which are to be used in vivo.
Satisfactory results were obtained in vivo only with cis-acting ribozy
mes. Altogether these results suggest that the ribozyme/substrate hybr
idization step is the limiting step in vivo and therefore it is not cl
ear if ribozymes represent an improvement over antisense RNAs.